semaglutide for dogs K9 Select SAMe 225mg Semaglutide for weight loss |

Implications for the weight loss drug market: Government restrictions on GLP-1 access in the UK provide an opportunity for private healthcare companies to meet consumer demand

The drug is also being tested in the clinic for another metabolic condition called hypothalamic obesity, which is characterized by uncontrollable weight gain caused by damage to the hypothalamus, the region in the brain that regulates basic bodily functions like appetite, thirst, and sleep

& Scharrer, E

Side-effect profile observed in research Nausea, diarrhoea, constipation, and vomiting were the most frequently reported events in the Phase 2 trial, generally mild-to-moderate and most common during the dose-escalation phase

Ongoing research The semaglutide-allodynia connection is an active area of investigation